The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The ‘therapeutic chelation’ approach to treating Alzheimer’s disease (AD) evolved from the metals hypothesis, with the premise that small molecules can be designed to prevent transition metal-induced amyloid deposition and oxidative stress within the AD brain. Over more than twenty years, countless in vitro studies have been devoted to characterizing metal binding, its effect on Aβ aggregation, ROS production and in vitro toxicity. Despite a lack of evidence for any clinical benefit, the conjecture that therapeutic chelation is effective approach for treating AD remains widespread. Here, the author plays the devil’s advocate, questioning the experimental evidence, the dogma and the value of therapeutic chelation, with a major focus on the role of copper ions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“…Aβ and AD is indirect (Herrup, 2015), soluble Aβ oligomers are widely viewed as toxic intermediates responsible for AD pathology (McLean et al., 1999; Selkoe, 2008) and sporadic AD has been associated with an inefficient clearance of Aβ from the central nervous system (Mawuenyega et al., 2010).”
BackgroundHydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · cited 1×
“…exogenous application of Aβ to cultured cells appears capable of causing oxidative damage that can be prevented by metal chelators or antioxidants (Behl et al., 1992, 1994; Manelli and Puttfarcken, 1995; Rosales-Corral et al., 2012), distinguishing direct metal-Aβ redox cycling from downstream…”
BackgroundNeurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · cited 2×
“, 1999), (iii) elevated concentrations of Aβ within the AD cortex as compared with unaffected individuals (Lue et al., 1999); and (iv) a “high” affinity of human Aβ for Cu2+.”
BackgroundResultRapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522 · cited 4×
“…2001); Met35 reduces Cu2+(Aβ) to an air-stable Cu+(Aβ) complex (Barnham et al., 2003a; Ciccotosto et al., 2004); Cu2+ cannot displace Zn2+ from Aβ1−40 (Bush et al., 1994b); the affinity of Aβ1−42 for Cu 2+ is 10 attomolar, seven orders of magnitude higher than that of Aβ1−40 (Atwood et al.,…”
BackgroundResultInfluentialCherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086 · cited 2×
“…dismutase-like di-copper binding site (Curtain et al., 2001; Tickler et al., 2005; Smith et al., 2006); Aβ generates ROS in the absence of metal ions (Hensley et al., 1994; Turnbull et al., 2001); Met35 reduces Cu2+(Aβ) to an air-stable Cu+(Aβ) complex (Barnham et al., 2003a; Ciccotosto et al.,…”
BackgroundThe Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060 · cited 1×
“Other potential physiological functions of Aβ1−40/42 have been proposed, as an antimicrobial peptide (Soscia et al., 2010; Kumar et al., 2016) and as a cerebrovascular sealant (Atwood et al., 2003), although any role for copper ions in these contexts remains to be established.”
BackgroundSoluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · cited 6×
“…seven orders of magnitude higher than that of Aβ1−40 (Atwood et al., 2000); rat and mouse Aβ bind Cu2+ much less avidly than human Aβ (Bush et al., 1994a; Atwood et al., 1998; Eury et al., 2011); Aβ does not aggregate in the absence of metal ions (Atwood et al., 2000; Bush and Tanzi, 2002);…”
BackgroundResultInfluentialKumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · cited 2×
“Other potential physiological functions of Aβ1−40/42 have been proposed, as an antimicrobial peptide (Soscia et al., 2010; Kumar et al., 2016) and as a cerebrovascular sealant (Atwood et al., 2003), although any role for copper ions in these contexts remains to be established.”
BackgroundIwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867
The case for rejecting the amyloid cascade hypothesis
Herrup, K. (2015) · Nature Neuroscience · doi:10.1038/nn.4017 · Cited by 768 · cited 2×
“, 2014) and some good arguments that the link between Aβ and AD is indirect (Herrup, 2015), soluble Aβ oligomers are widely viewed as toxic intermediates responsible for AD pathology (McLean et al.”
BackgroundCu(II) Potentiation of Alzheimer Aβ Neurotoxicity
Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37111 · Cited by 762 · cited 6×
“In vitro evidence for the ability of Aβ1−x to generate ROS in the presence of Cu2+ and biological reducing agents was quickly established (Huang et al., 1999; Opazo et al., 2002) although continues to be debated (Mayes et al., 2014; Pedersen et al., 2016; Reybier et al., 2016), while the underlying…”
BackgroundInfluentialBush, A. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00073-3 · Cited by 731 · cited 1×
“…supply of metal ions, notably copper, zinc, and iron, creates a “rogue” form of Aβ that promotes aggregation and, in the case of copper and iron, generates reactive oxygen species (ROS) that drive disease (Bush et al., 1994a; Bush, 2000, 2003, 2008; Bush and Tanzi, 2008; Duce et al., 2011).”
BackgroundLannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725
Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672
Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540
Miller, D. L., Papayannopoulos, I. A., Styles, J., Bobin, S. A., Lin, Y. Y., Biemann, K., & Iqbal, K. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1112 · Cited by 510
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497 · cited 4×
“These observations contrast with the founding principle of therapeutic chelation (Barnham and Bush, 2014).”
BackgroundResultInfluentialAqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal Depletion
Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Beyreuther, K., Tanzi, R. E., Masters, C. L., & Bush, A. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23223 · Cited by 482 · cited 6×
“Using prior Raman investigations of metal binding to synthetic Aβ (Miura et al., 2000) as a guide, Dong et al. (2003) concluded that Cu2+ (and Zn2+) were directly bound to Aβ in plaques, based upon intensity changes assigned to metal ion coordination to His side chains.”
BackgroundResultInfluentialAmyloid biomarkers in Alzheimer's disease
Blennow, K., Mattsson, N., Schöll, M., Hansson, O., & Zetterberg, H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.002 · Cited by 470 · cited 1×
“Nevertheless, most effort has been invested inmeasuring andmodulating levels of Aβ1−40/42 in the CNS as AD biomarkers (Blennow et al., 2015) and therapies (Wisniewski and Goñi, 2014; Ingelsson and Lannfelt, 2016), respectively.”
BackgroundNäslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., Silberring, J., Gandy, S. E., Winblad, B., & Greengard, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8378 · Cited by 468
Proteolytic Degradation of Amyloid -Protein
Saido, T., & Leissring, M. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006379 · Cited by 368 · cited 1×
“Of the Zn-dependent endopeptidases so far identified as Aβ degrading enzymes (Saido and Leissring, 2012; Jha et al., 2015), neprilysin (NEP; Howell et al., 1995; Kanemitsu et al., 2003) and insulin degrading enzyme (IDE; Morelli et al., 2004; Grasso et al., 2011) appear capable of cleaving the…”
BackgroundPortelius, E., Bogdanovic, N., Gustavsson, M. K., Volkmann, I., Brinkmalm, G., Zetterberg, H., Winblad, B., & Blennow, K. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0690-1 · Cited by 348
White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M. D., Evin, G., Cherny, R. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602487200 · Cited by 284 · cited 10×
“The above examples aside, there has also been a change in focus in recent years from metal ion interaction with Aβ as a driver of aggregation and toxicity to a more general picture of global metal ion dysregulation, in which direct metal-Aβ interactions play a secondary or even inconsequential role (White et al., 2006…”
BackgroundMethodInfluentialThe role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266 · cited 1×
“In other instances, there has been a synthesis of the two schools of thought, whereby an accumulation of metal ions in amyloid plaques is proposed to be responsible for the loss of normal metal ion balance (Hung et al., 2011; Ceccom et al., 2012; Roberts et al., 2012; Ayton et al., 2013).”
BackgroundAstrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease
DeWitt, D. A., Perry, G., Cohen, M., Doller, C., & Silver, J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6738 · Cited by 261 · cited 4×
“…2009), disruption of native metal binding sites, for example by treatment of crude brain homogenates by denaturation at 97◦C and 3mM sodium azide (DeWitt et al., 1998; Dong et al., 2003), may still lead to the release of metal ions from themany hundreds of proteins that are also found within…”
BackgroundMethodInfluentialProteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease
Drummond, E., Nayak, S., Faustin, A., Pires, G., Hickman, R. A., Askenazi, M., Cohen, M., Haldiman, T., Kim, C., Han, X., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1691-0 · Cited by 239
Robert, A., Liu, Y., Nguyen, M., & Meunier, B. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00119 · Cited by 212 · cited 1×
“A large number of metal chelators have been proposed as therapeutics for AD (e.g., Telpoukhovskaia and Orvig, 2013; Robert et al., 2015), while only a handful have been clinically trialed.”
BackgroundSarell, C. J., Wilkinson, S. R., & Viles, J. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171355 · Cited by 199
Bouter, Y., Dietrich, K., Wittnam, J. L., Rezaei-Ghaleh, N., Pillot, T., Papot-Couturier, S., Lefebvre, T., Sprenger, F., Wirths, O., Zweckstetter, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1129-2 · Cited by 175
Schieb, H., Kratzin, H., Jahn, O., Möbius, W., Rabe, S., Staufenbiel, M., Wiltfang, J., & Klafki, H. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246561 · Cited by 65
Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X
Antonios, G., Borgers, H., Richard, B. C., Brauß, A., Meißner, J., Weggen, S., Pena, V., Pillot, T., Davies, S. L., Bakrania, P., et al. (2015) · Scientific Reports · doi:10.1038/srep17338 · Cited by 61
Kenche, V. B., Zawisza, I., Masters, C. L., Bal, W., Barnham, K. J., & Drew, S. C. (2013) · Inorganic Chemistry · doi:10.1021/ic302289r · Cited by 59 · cited 4×
“Terdendate ligands (L) such as PBT2 can bind in a 1:1 (CuL) and a distorted 5-coordinate 1:2 (CuL2) form (Kenche et al., 2013), although the predominant Cu2+bound form of this class of terdentate 8HQ in a biological context is predicted to be a ternary (mixed-ligand)metal complex involving His side…”
BackgroundInfluentialSelf-citationMital, M., Zawisza, I. A., Wiloch, M. Z., Wawrzyniak, U. E., Kenche, V., Wróblewski, W., Bal, W., & Drew, S. C. (2016) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.6b00832 · Cited by 32 · cited 2×
“While CuL and CuL2 are not capable of generating hydroxyl radicals in the presence of the biological reductant such as ascorbate, the dominant ternary metal complexes can produce as many hydroxyl radicals as Cu(Aβ1−x) in vitro (Mital et al., 2016) and ROS production can be observed following addition of such 8HQs to n…”
BackgroundSelf-citationProbing the quaternary structure of metal-bridged peptide oligomers
Drew, S. C. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.01.012 · Cited by 10
Self-citation
Cited by
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185
Taylor, A. A., Tsuji, J. S., Garry, M. R., McArdle, M. E., Goodfellow, W. L., Adams, W. J., & Menzie, C. A. (2020) · Environmental Management · doi:10.1007/s00267-019-01234-y · Cited by 512
Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications
Gromadzka, G., Tarnacka, B., Flaga, A., & Adamczyk, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239259 · Cited by 339
Copper and Zinc Dysregulation in Alzheimer’s Disease
Sensi, S. L., Granzotto, A., Siotto, M., & Squitti, R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.10.001 · Cited by 285
Puentes-Díaz, N., Chaparro, D., Morales-Morales, D., Flores-Gaspar, A., & Alí-Torres, J. (2023) · ACS Omega · doi:10.1021/acsomega.2c06939 · Cited by 67
Metadata
- Authors
- Drew, S. C.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-06-02
- Volume
- 11
- Pages
- 317-317
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2621287228
- Cited by
- 91
- References
- 40
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.